Aptamer Group Ltd, a developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB, a developer and manufacturer of agarose-based purification technologies, have entered into an agreement to co-develop a new affinity resin for improved purification and scale up of gene therapy vectors.   Under the agreement, Aptamer Group will develop an Optimer ligand capable of binding and eluting a viral vector. Bio-Works Technol...